Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125334361 | 12533436 | 1 | I | 20151113 | 20160628 | 20160706 | 20160706 | EXP | US-ABBVIE-16P-163-1669699-00 | ABBVIE | 61.00 | YR | M | Y | 0.00000 | 20160706 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125334361 | 12533436 | 1 | PS | TECHNIVIE | OMBITASVIR HEMINONAHYDRATEPARITAPREVIR DIHYDRATERITONAVIR | 1 | Oral | UNKNOWN | 207931 | ||||||||||
| 125334361 | 12533436 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125334361 | 12533436 | 1 | Chronic hepatitis C |
| 125334361 | 12533436 | 2 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125334361 | 12533436 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125334361 | 12533436 | Gallbladder neoplasm | |
| 125334361 | 12533436 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125334361 | 12533436 | 1 | 20151007 | 20151229 | 0 | |
| 125334361 | 12533436 | 2 | 20151007 | 20151229 | 0 |